| Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses ML Precopio, MR Betts, J Parrino, DA Price, E Gostick, DR Ambrozak, ... The Journal of experimental medicine 204 (6), 1405-1416, 2007 | 558 | 2007 |
| Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1–infected subjects with progressive disease: changes after antiretroviral therapy A Harari, S Petitpierre, F Vallelian, G Pantaleo Blood 103 (3), 966-972, 2004 | 484 | 2004 |
| Dominant TNF-α+Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease A Harari, V Rozot, FB Enders, M Perreau, JM Stalder, LP Nicod, ... Nature medicine 17 (3), 372-376, 2011 | 483 | 2011 |
| HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells SC Zimmerli, A Harari, C Cellerai, F Vallelian, PA Bart, G Pantaleo Proceedings of the National Academy of Sciences 102 (20), 7239-7244, 2005 | 396 | 2005 |
| Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer JL Tanyi, S Bobisse, E Ophir, S Tuyaerts, A Roberti, R Genolet, ... Science translational medicine 10 (436), eaao5931, 2018 | 372 | 2018 |
| An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses A Harari, PA Bart, W Stöhr, G Tapia, M Garcia, E Medjitna-Rais, S Burnet, ... The Journal of experimental medicine 205 (1), 63-77, 2008 | 365 | 2008 |
| Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence A Harari, F Vallelian, PR Meylan, G Pantaleo The Journal of Immunology 174 (2), 1037-1045, 2005 | 358 | 2005 |
| Functional signatures of protective antiviral T‐cell immunity in human virus infections A Harari, V Dutoit, C Cellerai, PA Bart, RA Du Pasquier, G Pantaleo Immunological reviews 211 (1), 236-254, 2006 | 349 | 2006 |
| Standardization of cytokine flow cytometry assays HT Maecker, A Rinfret, P D'Souza, J Darden, E Roig, C Landry, P Hayes, ... BMC immunology 6, 1-18, 2005 | 277 | 2005 |
| Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities R McNerney, M Maeurer, I Abubakar, B Marais, TD Mchugh, N Ford, ... Journal of Infectious Diseases 205 (suppl_2), S147-S158, 2012 | 275 | 2012 |
| Novel technologies and emerging biomarkers for personalized cancer immunotherapy J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ... Journal for immunotherapy of cancer 4, 1-25, 2016 | 260 | 2016 |
| Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases G Pantaleo, A Harari Nature Reviews Immunology 6 (5), 417-423, 2006 | 256 | 2006 |
| Phenotypic heterogeneity of antigen‐specific CD4 T cells under different conditions of antigen persistence and antigen load A Harari, F Vallelian, G Pantaleo European journal of immunology 34 (12), 3525-3533, 2004 | 234 | 2004 |
| Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes C Chong, M Müller, HS Pak, D Harnett, F Huber, D Grun, M Leleu, ... Nature communications 11 (1), 1293, 2020 | 232 | 2020 |
| Mycobacterium tuberculosis‐specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease V Rozot, S Vigano, J Mazza‐Stalder, E Idrizi, CL Day, M Perreau, ... European journal of immunology 43 (6), 1568-1577, 2013 | 221 | 2013 |
| Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes J Racle, J Michaux, GA Rockinger, M Arnaud, S Bobisse, C Chong, ... Nature biotechnology 37 (11), 1283-1286, 2019 | 218 | 2019 |
| Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy GP Rizzardi, A Harari, B Capiluppi, G Tambussi, K Ellefsen, D Ciuffreda, ... The Journal of clinical investigation 109 (5), 681-688, 2002 | 212 | 2002 |
| Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy FG Herrera, C Ronet, M Ochoa de Olza, D Barras, I Crespo, M Andreatta, ... Cancer discovery 12 (1), 108-133, 2022 | 191 | 2022 |
| Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer A Cachot, M Bilous, YC Liu, X Li, M Saillard, M Cenerenti, GA Rockinger, ... Science advances 7 (9), eabe3348, 2021 | 182 | 2021 |
| Antitumour dendritic cell vaccination in a priming and boosting approach A Harari, M Graciotti, M Bassani-Sternberg, LE Kandalaft Nature Reviews Drug Discovery 19 (9), 635-652, 2020 | 167 | 2020 |
